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Abstract
Background: One facet of the complexity underlying the biology of HIV-1 resides not only in its
limited number of viral proteins, but in the extensive repertoire of cellular proteins they interact
with and their higher-order assembly. HIV-1 encodes the regulatory protein Tat (86–101aa), which
is essential for HIV-1 replication and primarily orchestrates HIV-1 provirus transcriptional
regulation. Previous studies have demonstrated that Tat function is highly dependent on specific
interactions with a range of cellular proteins. However they can only partially account for the
intricate molecular mechanisms underlying the dynamics of proviral gene expression. To obtain a
comprehensive nuclear interaction map of Tat in T-cells, we have designed a proteomic strategy
based on affinity chromatography coupled with mass spectrometry.
Results: Our approach resulted in the identification of a total of 183 candidates as Tat nuclear
partners, 90% of which have not been previously characterised. Subsequently we applied in silico
analysis, to validate and characterise our dataset which revealed that the Tat nuclear interactome
exhibits unique signature(s). First, motif composition analysis highlighted that our dataset is
enriched for domains mediating protein, RNA and DNA interactions, and helicase and ATPase
activities. Secondly, functional classification and network reconstruction clearly depicted Tat as a
polyvalent protein adaptor and positioned Tat at the nexus of a densely interconnected interaction
network involved in a range of biological processes which included gene expression regulation,
RNA biogenesis, chromatin structure, chromosome organisation, DNA replication and nuclear
architecture.
Conclusion: We have completed the in vitro Tat nuclear interactome and have highlighted its
modular network properties and particularly those involved in the coordination of gene expression
by Tat. Ultimately, the highly specialised set of molecular interactions identified will provide a
framework to further advance our understanding of the mechanisms of HIV-1 proviral gene
silencing and activation.
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Background
HIV-1 encodes the nuclear regulatory protein Tat, which is
essential for HIV-1 replication and which primarily
orchestrates HIV-1 provirus transcriptional regulation. Tat
transactivation from the viral promoter (LTR), is highly
dependent on complex interactions between Tat, the short
leader RNA present in the 5' region of all nascent HIV-1
transcripts, TAR (Trans-activation responsive element),
and a number of host cellular proteins [1-4]. The molecu-
lar mechanisms whereby HIV-1 gene expression is regu-
lated by Tat occurs at distinct levels. Initially, Tat enhances
transcription initiation by promoting the assembly of the
RNA polII complex by interacting with various transcrip-
tion factors [2]. Subsequently, Tat activates elongation via
two independent mechanisms: firstly, it enhances the
processivity of RNA polII by interacting with elongation
factors such as pTEF-b, which phosphorylates RNA polII
C-terminal domain, and secondly, by recruiting histone
acetyltransferase proteins which modify the chromatin
template such as p300/CBP (CREB binding protein) and
p300/CBP-associated factor (PCAF) and, as recently
described, by interacting with BRM and BRG1, two chro-
matin remodellers[5-10]. Although the recruitment of
these specific cellular factors by Tat to the HIV-1 LTR are
crucial for Tat function, they only partially account for the
intricate molecular mechanisms underlying the dynamics
of proviral gene expression. Furthermore, Tat can be
secreted by infected cells and extracellular Tat can exert
autocrine or paracrine activities via interactions with cell
surface receptors including integrins, CXCR4, CD26,
HSPG and LRP[11].
While Tat is a small and compact protein, composed of
only 86 or 101 amino acids, sequence and functional
analysis reveals that Tat sequence encompasses a unique
arrangement of five distinct and contiguous regions
including the acidic, cysteine-rich, core, basic and
glutamine-rich regions. Furthermore, Tat is subject to
post-translational modifications, such as acetylation,
methylation, phosphorylation and ubiquitination, thus
increasing both the number and diversity of potential
interfaces between Tat and cellular proteins [12-14].
Recently, a structural study employing nuclear magnetic
resonance (NMR) spectroscopy has described Tat as a
"natively unfolded" protein with fast dynamics lacking a
well-structured three-dimensional fold. These characteris-
tics would provide Tat the flexibility to interact with
numerous cellular partners. Collectively these findings
suggest that Tat is a potent, versatile protein suited for
multiple interactions and highlights the concept that
numerous protein-protein interactions underlie the
molecular mechanisms of HIV-1 molecular pathogenesis
[15-19].
In this report, we have attempted to further investigate the
interplay of Tat with host cell proteins. Specifically, we
have designed a proteomic strategy based on affinity chro-
matography (AC) coupled with mass spectrometry (MS)
to purify Tat interacting proteins from T-cell nuclear
extracts (Figure 1). Our approach has produced the in vitro
Tat nuclear interactome, which includes a total of 183
individual nuclear components, most of which have not
been previously identified as Tat partners. We subse-
quently applied in silico analysis, to validate our dataset
and develop HIV-1 Tat interaction network maps. In this
report, we have focused on the description of multi-pro-
tein complexes involved in gene expression regulation,
which comprised the majority of our dataset and which
clearly reflects Tat primary function.
Results
Experimental Design
To identify multi-protein complexes associated with HIV-
1 Tat, we employed the experimental strategy depicted in
Figure 1. Our priority was to ensure a highly sensitive and
specific methodology to identify both transient interac-
tions and low-abundance proteins associated with com-
plexes, while ensuring potential contaminants (false
positives) remained as low as possible. In this study, we
focused on nuclear protein interactions as Tat has been
shown to primarily localise in the nucleus. Protein com-
plexes were identified using in vitro "pull down" purifica-
tion employing equivalent amounts of immobilised
recombinant GST-Tat (bait) and GST (negative control)
proteins, and incubation with T-cell nuclear extracts. Fol-
lowing extensive washes, captured protein complexes
were eluted under denaturing conditions (Laemmli
buffer) and resolved using a 1D SDS-PAGE gel. For pro-
tein identification, GST and GST-Tat interaction profiles
within the entire separation range of each SDS-PAGE gel
lane were systematically sliced into 2 mm gel pieces and
subjected to in-gel tryptic digestion. Peptide mixtures
were separated by liquid chromatography (LC) prior to
tandem mass spectrometry analysis (MS/MS). The iden-
tity of selected proteins was validated by Western Blot
(WB) analysis.
Tat Interaction Profile
Jurkat T-cell nuclear extracts were prepared as described in
Materials and Methods and subjected to affinity chroma-
tography (AC) with GST or GST-Tat. GST, GST-Tat and
their respective associated proteins were eluted and sepa-
rated by SDS-PAGE (Figure 2). A total of 164 gel slices
from the GST and GST-Tat lanes were processed and the
resulting tryptic peptides were analysed by LC-MS/MS. We
successfully identified over 250 proteins with sizes rang-
ing from 25 kDa to 400 kDa, which did not interact withRetrovirology 2009, 6:47 http://www.retrovirology.com/content/6/1/47
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GST alone. Proteins were identified with a minimum of
two individual peptides (see Table 1 and Additional file
1). In effect, we obtained a moderate to high amino acid
sequence coverage by matching tryptic peptides, ranging
from 2.5% (MLL) up to 71% (prohibitin), which was
inversely correlated with increasing protein size.
Dataset Curation Process
To eliminate potential contaminants from the dataset, we
modified our preliminary dataset by retaining proteins
known to exist in the nucleus and excluding non-nuclear
components such as those associated with mitochondria,
cytoskeletal proteins, and common contaminants such as
keratin, and ribosomal and histone proteins. The resulting
dataset contained 183 candidate proteins that could inter-
act directly or indirectly with HIV-1 Tat. Remarkably, 10%
of the selected proteins have been previously identified by
other studies, demonstrating the effectiveness and robust-
ness of our approach (Table 1)[5,6,20-38]. The remain-
der, not previously described, highlighted the potential of
our approach to identify new interactions. We subse-
quently confirmed the identity of 11 proteins identified as
new Tat interactors by Western-Blotting analysis (Figure
3). Furthermore, these interactions appear to be robust
since some of them, like SIN3A or HDAC1 could tolerate
washes containing up to 1 M NaCl (Figure 3A). The spe-
cificity of these interactions was further confirmed,
employing a Tat-NLS deletion mutant, which still bound
with 5 of them (SIN3A, HDAC1, SAP18, Ikaros and
SPT16) (Figure 3B). Of note however, our study did not
identify certain proteins known to interact with Tat,
including cyclin T1, TIP60, P/CAF or BRM[6,8,9,39-41].
However, when we performed GST pull-down with
nuclear extract followed by Western-Blot (WB), we could
Overview of our proteomic strategy for isolating and identifying Tat interacting proteins from T-cell nuclear extracts Figure 1
Overview of our proteomic strategy for isolating and identifying Tat interacting proteins from T-cell nuclear 
extracts. Schematic representation of our experimental design based on Affinity Chromatography (AC) coupled with Mass 
Spectrometry (MS) approach (see text for details).
Affinity Chromatography Affinity Chromatography
T-cell Nuclear Fraction
+
LC-ESI MS/MS LC-ESI MS/MS
analysis analysis
1D-Gel
Unspeciﬁc binding
Elution
Separation
Trypsin
Digestion
Wash
Immobilised
GST-Tat
Tat-interacting protein
complexes
Interaction Map
In silico
analysisRetrovirology 2009, 6:47 http://www.retrovirology.com/content/6/1/47
Page 4 of 18
(page number not for citation purposes)
specifically detect the presence of Cyclin T1 in the Tat-
eluted fraction, confirming that our recombinant GST-Tat
is competent to interact with this well characterised
nuclear partner (Figure 3A).
Dataset Validation Process
In the initial analysis of our dataset, we analysed the
domain composition of each protein using CDD, Pfam
and Smart databases[42-47]. The 10 most prevalent
domains found within the entire dataset are listed in Table
2, where their frequency was compared against their
expected frequency derived from the Nuclear Protein
Database (NPD) Protein Domains[48,49]. Interestingly,
the dataset is highly enriched for interaction domains of
RNA (RRM, DEXDc, DSRM) and DNA (HMG and SANT)
recognition motifs [50-53]. Other enriched interaction
domains are well known to be involved in mediating pro-
tein-protein interactions and include the PHD, WD40,
RRM or Bromodomain motifs [51,54-56]. Finally, the
only enriched domains associated with a catalytic activity
were the AAA domain, which is associated with diverse
ATP-dependent functions and the DEXDc and HELICc
domains, which have a helicase activity[50,57]. Several of
these have been previously shown to mediate interactions
of cellular proteins with Tat. The protein DICER has been
shown to interact with Tat via its DEXDc domain, in an
RNA-dependent manner[58]. The WD40 domain of LIS1
also interacts with Tat, and the Bromodomain of P/CAF
specifically recognises the acetyl-lysine (K50) in
Tat[9,59,60].
When examined individually, these domains are versatile,
and occur in a wide variety of proteins. However, collec-
tively, they are frequently found in individual proteins or
large complexes associated with key functions in gene
expression regulation, and more specifically at the level of
chromatin remodelling (HMG, PHD, BROMO, AAA,
DEXDc, HELICc, SANT, WD40), gene transcription (RRM,
HMG, DSRM, WD40), RNA processing (AAA, RRM,
DEXDc, HELICc DSRM) and DNA replication/chromo-
some structure (AAA, SANT)[50-57,61-67].
Overall, the protein domain analysis exhibited two dis-
tinct features: (i) our dataset appears to be specifically tai-
lored to interact with molecules such as RNA, DNA and
proteins; (ii) our dataset is highly specialised in gene
expression regulation and DNA replication.
To examine functional composition, systematic gene
annotation employing the online tool (G.O.) was carried
out, and the entire dataset was organised according to the
protein involvement in specific biological proc-
esses[68,69]. This resulted in the distribution of the pro-
teins over 8 categories, ranging from transcription to DNA
replication (Figure 4). Hence, Tat interacts with specific
cellular components associated with a range of distinct
activities, which may account for the marked pleiotropic
activities of the protein. The best represented biological
processes include transcription, RNA processing and
translation, which collectively accounted for 64% of our
Table 1: Previously characterised Tat interaction partners.
Symbol G.O. Process TurboSEQUEST Score Coverage % KD Accession (GI) MS/MS Peptide no. Ref
BRG1 Transcription 258.28 18.9 184529.4 21071056 32 (31 1 0 0 0) 5
INI1 Transcription 40.25 18.30 40666.5 3326993 4 (4 0 0 0 0) 22
BAF170 Transcription 70.26 8.20 132649.7 1549241 7 (7 0 0 0 0) 6
CTIP2 Transcription 70.22 12.8 88420.5 12597635 8 (8 0 0 0 0) 35
ILF2 Transcription 70.35 26.60 44669.4 1082855 11 (10 1 0 0 0) 27, 30
ILF3 Transcription 60.22 16.6 61936.8 9714272 6 (6 0 0 0 0) 27,30
YBX1 Transcription 30.25 16.7 35902.7 27807361 6 (6 0 0 0 0) 21
POLR2A Transcription 130.28 12 217042.6 7434727 14 (14 0 0 0 0) 24
TAF15 Transcription 20.22 5.4 61520.8 4507353 2 (2 0 0 0 0) 28
ERCC2 Transcription 30.16 5.6 83419.5 296645 3 (3 0 0 0 0) 26, 39
POLR2B Transcription 40.22 5.1 133810.7 4505941 4 (4 0 0 0 0) 24
BTAF1 Transcription 120.24 11.1 206754.5 27477070 12 (12 0 0 0 0) 28
c1qbp RNA processing 30.29 23.00 30888.4 338043 5 (5 0 0 0 0) 23
NPM1 RNA processing 126.31 38.8 32582.9 33694244 43 (42 0 1 0 0) 29
EEF1D Translation 50.27 11.6 71378.2 14043783 5 (5 0 0 0 0) 37
CDC2 Cell cycle 158.31 58.1 34187 30584091 22 (21 1 0 0 0) 33
PPP1CC Cell cycle 40.29 18.60 36959.8 4506007 4 (4 0 0 0 0) 20
RFC1 DNA replication 50.24 6.2 128174 2136100 5 (5 0 0 0 0) 24
LMNB nucleus organization 126.22 24.2 66367.7 5031877 13 (12 0 1 0 0) 31, 32
KPNB1 nucleus organization 70.25 11.5 97108.2 19923142 7 (7 0 0 0 0) 36
List of the proteins identified by LC-MS/MS corresponding to known Tat interaction partners. Amino acid coverage (Coverage %), number of MS/
MS peptides used for the identification (MS/MS peptide no), TurboSEQUEST score, GenInfo Identifier (GI) for protein and gene ontology (GO) 
analysis (cellular process) for each identification are indicated.Retrovirology 2009, 6:47 http://www.retrovirology.com/content/6/1/47
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dataset. Other major biological processes include cell
cycle (13%) and nucleus organisation (8%).
HIV-1 Tat Interaction Map
Construction and mapping of the Tat interaction network
While informative, linear analysis of the Tat interaction
dataset is inadequate to fully appreciate the higher order
organisation of the Tat interactome. As such, we con-
structed a network representation of the Tat interactome
and subjected our dataset to in silico interaction analysis
and employed Osprey as a visualisation tool[70]. We
employed established PPI databases such as BIND and
HPRD, complemented by extensive literature searches, to
map previously characterised interactions between the
candidate proteins and developed a detailed protein inter-
action network[71-74]. This is depicted in Figure 5[75-
233].
Global network characteristics
Within the interaction map we included interactions
involving a minimum of two proteins. Non-interacting
and self-interacting proteins were excluded to simplify the
network representation. The resulting network consists of
129 proteins linked by 299 interactions, with an average
of 2.31 interactions per protein. Some proteins were
highly connected, such as HDAC-1 and -2, which display
a total of 23 and 23 interactions, respectively. A striking
result of this mapping process was the identification of
groups of proteins, which formed distinct and well-con-
nected sub-networks corresponding to previously charac-
terised multi-protein complexes (see below). These well-
defined clusters are involved in complementary, consecu-
tive and/or opposite steps of gene expression regulation,
epigenetic control, chromosome and nuclear architecture.
They include transcriptional repressors, such as SIN3/
HDAC, NuRD, PRC2, MeCP1, and activators including
SET, FACT, BAF53, SWI2/SNF2 and WICH; chromosome
organisation factors including condensin, cohesin, topo-
some, minichromosome maintenance (MCM), and origin
of replication complex (ORC); and nuclear structure
including lamina, NPC and transport factors. Interest-
ingly, the complexes could also be shown to be intercon-
nected, which is a reflection of the fact that multiple
proteins are shared between distinct complexes, as exem-
plified by RbAp46 and RbAp48, subunits of the SIN3/
HDAC, NuRD and PRC2 complexes. Alternatively, other
complexes (such as FACT) remain isolated with protein
interactions solely restricted to the members of that com-
plex.
Functional modules
Subdivision of the Tat interaction network into functional
modules enabled us to gain insights into the functional
properties of the multi-protein assembly. The depicted
multi-subunit complexes are (i) chromatin modifying fac-
Interaction profile of Tat associated proteins, isolated from  Jurkat nuclear fractions Figure 2
Interaction profile of Tat associated proteins, iso-
lated from Jurkat nuclear fractions. T-cell nuclear 
extracts were incubated with immobilised GST (control) and 
GST-Tat (Bait). Specifically interacting proteins were subse-
quently eluted and resolved by SDS-PAGE and stained with 
Coomassie Blue. The resulting Tat interaction profile is spe-
cific and composed of bands of distinct size and intensity, 
representing putative proteins interacting with Tat. The puri-
fied recombinant proteins GST and GST-Tat are indicated by 
an arrowhead.
GST
GST-TatRetrovirology 2009, 6:47 http://www.retrovirology.com/content/6/1/47
Page 6 of 18
(page number not for citation purposes)
tors, which play central roles in the alteration of the struc-
ture and composition of chromatin, and are associated
with the activation or repression of gene expression; (ii)
chromosome organisation factors implicated in mitosis
and DNA replication and (iii) nuclear structure compo-
nents which participate in the nuclear architecture.
Activators of transcription
SET1
The Set1 histone methyltransferase complex includes,
Setd1A, Ash2, CXXC1, RBBP5, WDR5 and
Wdr83[234,235]. The SET1 complex mediates the methyl-
ation of Lys4 in histone H3, which ultimately results in
the activation of transcription. Three components
(Setd1A, CXXC1, WDR5) of this complex were identified
in the co-eluate by MS/MS and the presence of WDR5 was
further confirmed by GST pull-down followed by WB
analysis (Figure 3).
FACT
The heterodimeric FACT complex (SPT16-SSRP1) has
been characterised as an elongation factor, which enables
RNA polymerase II to progress through the chromatin
template, once transcription has been initiated[236].
FACT acts as a histone chaperone and mediates the disas-
sembly and reassembly of H2A/H2B dimers. Both SPT16
and SSRP1 were identified by AC-MS/MS. We further con-
firmed the presence of SPT16 in the co-eluate by WB (Fig-
ure 3).
BAF53, TRRAP/p400
TRRAP/p400 is a chromatin remodeling complex, part of
the INO80 family, characterised by a unique subunit com-
position and the presence of a distinct ATPase[237]. The
core of the p400/TRRAP complex, consists of BAF53A,
P400, RUVBL1, RUVBL2, TRRAP. These components were
identified by our AC-MS/MS approach, and the presence
of BAF53A was further validated by WB analysis of GST-
pull down products (Figure 3). Additional subunits,
including YEATS4, DMAP1 and Eaf6, known to be part of
the p400/TRRAP complex, were also identified by our
approach. Intriguingly, the TIP60 protein, which has been
described in distinct protein complexes harboring p400,
BAF53A and TRRAP and is a well characterised interaction
partner of Tat, was not detected in the co-eluate[40].
SWI2/SNF2
SWI2/SNF2 is another chromatin remodeling complex,
part of the SWI/SNF family[238]. Here, we have identified
most of the components of BAF (BRG1/BRM, BAF250,
BAF170, BAF155, BAF60a, BAF53A, actin and InI) and
PBAF (BRG1, BAF180, BAF170, BAF155, BAF60a,
BAF53A, actin and InI) complexes except BRM, BAF155
and BAF57. Importantly, BRM, BRG1, InI1 and BAF170
were previously shown to interact with Tat[5,6,22].
WICH
The WICH complex, composed of WSTF and SNF2H, is a
member of the ISWI-containing chromatin remodeling
complexes[239]. In addition to its role in replication, it
has been suggested that because of its association with
various transcription factors, it may have a role in tran-
scription. Of note, both subunits were identified by AC-
MS/MS and the presence of SNF2H in the co-eluate fol-
lowing GST pull-down was confirmed by WB (Figure 3).
Repressors of transcription
SIN3/HDAC
SIN3/HDAC is composed of SIN3A, SAP30, SAP18,
HDAC-1 AND -2 and RbAp46/48 and remarkably, all of
Validation of the identity of selected proteins interacting with  Tat Figure 3
Validation of the identity of selected proteins inter-
acting with Tat. A. GST pull-downs were performed with 
immobilised GST or GST-Tat and Jurkat cell nuclear extracts 
(150 μg) followed by washes with increasing salt (NaCl) con-
centration (0.3 M, 0.5 M, 0.8 M and 1 M). Eluates were ana-
lysed by WB using the indicated antibodies. B. GST pull-
downs were performed with immobilised GST or GST-Tat-
NLS and Jurkat cell nuclear extract (150 μg) followed by 
washes with 300 mM NaCl. Expression levels of each endog-
enous protein are provided with the Input corresponding to 
2 μg of nuclear extracts.
Cyclin T1
SIN3A
SNF2H
HDAC1
Ikaros
MTA1
SAP18
SPT16
BAF53A
WDR5
In
p
u
t GST GST-Tat
0.3M 0.5M 0.8M 1M 0.3M( NaCl)
A
B
In
p
u
t
GST-
Tat-NLS
SIN3A
SPT16
Ikaros
HDAC1
SAP18
GST
RbAp46/48
A
c
t
i
v
a
t
o
r
s
 
o
f
t
r
a
n
s
c
r
i
p
t
i
o
n
R
e
p
r
e
s
s
o
r
s
 
o
f
t
r
a
n
s
c
r
i
p
t
i
o
n
81kDa
145kDa
120kDa
59kDa
63kDa
80kDa
18kDa
140kDa
53kDa
40kDa
48kDa
145kDa
140kDa
63kDa
59kDa
18kDaRetrovirology 2009, 6:47 http://www.retrovirology.com/content/6/1/47
Page 7 of 18
(page number not for citation purposes)
these proteins except SAP30 were recovered and identified
by our approach. Additionally, the presence of HDAC-1,
RbAp46/48, SAP18 and SIN3A in the co-eluate following
GST pull-down was confirmed by WB (Figure 3). SIN3/
HDAC has been described as a global regulator of tran-
scription; indeed, SIN3A mediates additional interactions
with transcription factors and co-repressors, which direct
SIN3/HDAC to specific promoters[240]. SIN3A deacety-
lase activity is mediated by the HDAC-1 and -2 proteins
and results in transcriptional repression. Of note, while
the presence of HDAC proteins, SIN3A at the level of the
HIV-1 LTR has been previously demonstrated, this is the
first report showing that Tat interacts with these pro-
teins[241].
NuRD
NuRD shares with SIN3/HDAC four individual compo-
nents which include HDAC-1 AND -2 and RbAp46/48
and additionally contains CDH4/Mi-2, MTA1/2, MBD3,
and MINT. NuRD is recruited to target genes via DNA-
binding proteins, such as Ikaros identified here by our
approach and validated by WB (Figure 3)[242]. In addi-
tion to its HDAC activity, NuRD has an ATP-dependent
nucleosome activity carried out by CHD4/Mi-2, a chro-
matin-remodelling ATPase protein, which encompasses a
chromodomain of the SWI/SNF family. While we con-
firmed the presence of MTA1, we failed to detect NuRD in
the co-eluate by WB analysis. Interestingly, the presence of
MTA1 at the level of the HIV-1 LTR has been previously
demonstrated[243].
MeCP1
MeCP1, also shares the HDAC-1/-2 and RbAp46/48 sub-
units and include the methyl-CpG-binding protein MBD2
and p66alpha identified by our approach[84,244-247].
MeCP1 specifically recruits SIN3/HDAC or NuRD to DNA
methylation sites recognised by MBD2, which represents
an alternative mechanism mediating methylation-
dependent transcriptional repression involving histone
deacetylation and chromatin remodeling.
PRC2
RbAp46/48 are subunits of the Polycomb Repressive
Complex 2 (PRC2), which also include EED, EZH1,
EZH2, SUZ12. PRC2 can methylate lysine residues (K9
and K27) of histone H3[248]. This ultimately results in
the repression of gene expression. Here we have identified
SUZ12.
Replication and chromosome organisation factors
Condensin/Cohesin
The structural maintenance of chromosomes (SMC) pro-
teins form the core of the cohesin and codensin com-
plexes[249]. They are principally involved in
Table 2: Most representated protein motifs in the Tat 
interactome dataset.
Motif N Dataset % Dataset % Nucleus
RRM 16 8.4 6.3
HELIC 16 8.4 4.4
DEXDc 16 8.4 3.8
AAA 12 6.3 1.4
BROMO 10 5.2 1.5
HMG 10 5.2 1.9
SANT 8 4.2 1.4
WD40 7 3.7 3.4
PHD 5 2.6 3.2
DSRM 5 2.6 0.7
The number of appearance and percentage of each of the motifs are 
shown. N Dataset: Number of proteins in Tat interactome dataset 
possessing motif annotation. % Dataset: percentage of proteins in Tat 
interactome dataset possessing motif annotation. % Nucleus: 
percentage of proteins in Nuclear Protein Database (NPD) possessing 
motif annotation.
Functional distribution of Tat interaction dataset Figure 4
Functional distribution of Tat interaction dataset. 
The assignment of the protein dataset to cellular processes 
according to G.O. is summarised in the pie chart diagram and 
the percentage is shown.
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chromosome condensation and cohesion and play an
essential role into chromatid pairing and chromosome
segregation during mitosis. Interestingly, recent studies
have described their participation into transcriptional reg-
ulation and epigenetic processes. Here we have identified
the following condensin I subunits, SMC2, SMC4, CAPG,
CAPD2 and CAPH; and the following cohesin subunits:
SMC3, PDS5A, and PDS5B to be part of the Tat nuclear
interactome.
TOPOSOME
The toposome complex consists of the topoisomerase IIα
associated with RNA helicase A (RHA), SSRP1, PRP8,
hnRNP C and RHII/Gu[142]. This complex is involved in
Tat interaction network Figure 5
Tat interaction network. Here we mapped, using Osprey as a visualization tool, previously established interactions between 
the individual components of the Tat interaction dataset employing publicly available protein-protein interaction databases 
(BIND and HPRD) combined with extensive literature search. The network reconstruction of the Tat interactome revealed 
the higher-order and collective behaviour of the Tat interacting proteins, which compose large but well defined biochemical 
entities, represented by coloured circles. Edges represent interactions and individual proteins are depicted as nodes. Names in 
bold and red indicate the previously known Tat interactors and names in bold and blue represent proteins which identity was 
validated by WB analysis.
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chromosome condensation and segregation and it has
been suggested that topoisomerase functions in collabo-
ration with the condensing complex[250]. We have iden-
tified topoisomerase IIα, RHA, PRP8 and RHII/Gu as part
of our Tat interaction dataset.
MCM
The minichromosome maintenance (MCM) proteins are
essential for DNA replication and include six members:
MCM2–MCM7 which form an heterohexamer complex
that binds to DNA replication origins[64,251]. Additional
complexes include MCM4/6/7 or MCM3/5. It has been
suggested that these complexes play additional cellular
roles such as transcriptional regulation and chromatin
remodelling. Here we have identified three members of
the MCM family, MCM3, MCM6 and MCM7
ORC
The origin of replication complex is essential for DNA rep-
lication initiation[252]. The binding of the ORC complex
marks the origin of replication, where the MCMs proteins
are subsequently recruited and uploaded to form the pre-
replication complex. However, ORC localisation is not
restricted to the origin of replication and has been impli-
cated to a broader spectrum of activities such as silencing
and transcriptional regulation, heterochromatin assem-
bly, nucleosome remodeling and chromosome condensa-
tion[252].
Nuclear structure components
NPC and nuclear transport machinery
The Nuclear Pore Complex (NPC) located in the nuclear
envelope (NE) is composed of the outer nuclear mem-
brane (ONM) and the inner nuclear membrane (INM),
and enables the selective transport of macromolecules in
and out of the nucleus[253]. It is composed of over 30
nucleoporins. Here, we have identified several nucleop-
orins (Nup358, Nup205, Nup153, Nup98, Nup93,
Nup88, Nup85) and NPC associated proteins including
nuclear transport factors (KPNA2, KPNB1, XPO1,
RANGAP1 and RAN) and microfilaments/tubule (TUBB3,
TUBBA2, NUMA1 and DNCL1)
LAMINA
The nuclear lamina lines the INM and is composed of
lamins and NE lamin binding proteins including Nesprin-
1 alpha, MAN1, lamina-associated polypeptides-1 and 2
(LAP1, LAP2), emerin and Lamin B receptor[254,255].
The four latter and Lamin B (LMNB) have been identified
by our screen as components of the Tat nuclear interac-
tome
These results further substantiate the concept that chro-
mosome architecture, chromatin remodeling, epigenetic
control and nuclear organisation constitute pivotal mech-
anisms in the regulation of HIV-1 provirus gene expres-
sion and underscore the diversity of essential biological
tasks influenced by Tat interactions.
Discussion
While considerable efforts have been dedicated to charac-
terise individual proteins or specific macromolecular
complexes interacting with Tat, no comprehensive charac-
terisation of the Tat interactome has yet been reported. To
place Tat into a wider context of interacting systems and
pathways, we systematically analysed protein complexes
interacting with Tat within the nucleus, by performing
subcellular fractionation followed by AC-MS/MS. This
experimental approach is prone to introducing technical
artifacts or false positives which can then bias the subse-
quent analysis. To reduce this, we filtered the raw list of
proteins, removed potential contaminants and obtained a
final dataset of 183 interaction candidates. Subsequently,
we employed computational tools and in silico analysis to
validate our interaction dataset and to generate a Tat-
interaction network representation. This has resulted in
the in vitro Tat nuclear interactome in Jurkat T-cells.
Our studies have revealed that the Tat nuclear interactome
exhibits unique signature(s). The motif composition anal-
ysis underlines the enrichment for domains mediating
protein, RNA and DNA interactions, which collectively are
highly representated in transcription, chromatin remodel-
ling, chromosome structure and RNA processing com-
plexes. We also noted the enrichment of three crucial
motifs (HELIC, DEXDc and AAA) associated with helicase
and ATPase activities essential for RNA processing, chro-
matin remodeling and chromosome architecture, which
constitute the basis of both DNA replication and gene
expression regulation. In support of this, the functional
analysis demonstrated that proteins involved in chroma-
tin remodeling, transcription regulation and RNA process-
ing constitute the greater part of our dataset. Finally, the
network reconstruction of the Tat nuclear interactome
revealed the higher-order and collective behaviour of the
Tat-interacting proteins, which compose large but well
defined biochemical entities, involved in critical pathways
mediating gene expression regulation, chromosome/
chromatin structure, and nuclear architecture. Taken
together, the remarkable enrichment for essential proteins
together with their corresponding macromolecular com-
plexes, and their roles in both activation and repression of
gene expression indicate that the described Tat-interac-
tome might act as a modular switch committed to control
HIV-1 gene expression.
The presence of numerous, previously identified Tat-inter-
acting partners further validates our dataset. Conversely,
critical Tat cellular partners previously identified were not
identified by our experimental approach. This could beRetrovirology 2009, 6:47 http://www.retrovirology.com/content/6/1/47
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the result of the level of endogenous expression of these
proteins in Jurkat cells and perhaps technical limitations
including the following: (i) loss of a fraction of the pro-
teins during the sub-cellular fractionation step; (ii) pro-
teins resistant to trypsin digestion; (iii) proteins not
detected by the MS/MS step; (iv) absence of specific Tat
post-translational modifications on our recombinant
bait, GST-Tat, which is produced by a bacterial expression
system. Indeed, Tat interaction with its cellular partner
has been shown to be regulated by the acetylation state of
its lysines 28, 50 and 51. Interaction of cyclinT1 with Tat
requires the acetylation on lysine 28, while acetylation on
lysine 50 prevents Tat interaction with Brm but is neces-
sary for its interaction with BRG1 [5-7,256,257]. Never-
theless, despite absence of CyclinT1 from our interaction
dataset, we were able to detect it by WB, further establish-
ing our recombinant GST-Tat as a suitable bait.
Our experimental approach does not enable us to distin-
guish direct from indirect interactions. Furthermore,
while we treated our nuclear extract with the Benzonase®
nuclease (included as part of the ProteoExtract® Subcellu-
lar Proteome Extraction Kit (Calbiochem)), which has
both a DNase and an RNase activities, we cannot exclude
that some of the observed interactions could be mediated
by residual nucleic acids.
To explore the Tat interaction network in detail, we parti-
tioned the interacting candidates into coherent functional
modules, based on their reciprocal interactions. Our
results further support the recently described role of SNF
proteins in Tat-dependent transcription of the provirus[5-
7,22,258,259]. Indeed, we have identified BRG1 and the
various components of its related complex, SWI2/SNF2.
We have also identified for the first time, WICH, an ISWI
complex as a candidate Tat interactor.
Other complexes with histone-modifying activities
include TRRAP/p400, a histone acetylase, and SET1, a his-
tone methylase, both of which have critical positive effects
on transcription. In addition, we isolated the histone
chaperone FACT, directly involved in promoting the
processivity of RNA polII through the chromatin tem-
plate, which appears to be of relevance for Tat function in
transcription elongation[236].
Importantly, we have provided the first evidence describ-
ing a direct or indirect interaction of Tat with cellular pro-
teins, including YY1, HDAC-1/-2, and the components of
the SIN3/HDAC and NuRD complexes, previously
reported to interact with the integrated HIV-1 LTR.
Indeed, earlier studies have identified the presence of
HDAC-1 and -2 at the HIV-1 LTR in HeLa cells containing
an integrated HIV-1 LTR reporter, as well in latently HIV-
1 infected cell lines (ACH2, U1, J-Lat 6.3)[260-266]. They
mediate histone deacetylation of nuc-1, the nucleosome
positioned immediately downstream of the transcription
start site, and are believed to be one of the processes medi-
ating HIV-1 provirus transcriptional silencing throughout
the establishment and/or maintenance of HIV-1 latency.
In addition, two recent studies have identified the pres-
ence of SIN3A and MTA1, a component of the NuRD
complex, at the integrated HIV-1 LTR in Jurkat cells,
respectively recruited by CBF-1 and CTIP2[241,243].
While various studies have shown that several transcrip-
tion factors (NF-κB (p50), AP-4, YY-1, c-myc, SP1, CBF-1
and LSF) can recruit HDAC-1 and -2, and SIN3A or MTA1
to the HIV-1 LTR, the molecular mechanism(s) regulating
the activity and/or presence of HDAC-1/-2 and their asso-
ciated complexes at the integrated HIV-1 LTR has not been
fully elucidated[241,243,260-266]. The interaction of
HIV-1 Tat with the SIN3/HDAC and NuRD complexes fur-
ther implicates them as potential epigenetic regulators of
HIV-1 post-integration latency and suggests how Tat
might intersect with epigenetic pathways.
Alternatively, the enzymatic activities of the multi-protein
complexes recruited by Tat, such as methylation, acetyla-
tion and deacetylation, could be directed to Tat itself and
mediate post-translational modifications, as it has been
shown previously with PCAF, p300/CBP, SIRT1, or
SETDB1/2 [13,14,267,268].
Accumulative evidence has recently described how cellu-
lar proteins belonging to the DNA replication and the
mitotic chromosome condensation machineries have
been shown to carry out additional activities in gene
expression regulation and/or silencing by selectively
affecting the chromatin/chromosome architecture during
the interphase. The identification of Tat interactions with
multiple components of the cohesin, condensin, topo-
some, MCM and ORC complexes provide us with a new
prospective on how these pathways might also influence
Tat function and HIV-1 provirus expression and silencing.
In addition to its role in regulating the access of specific
regulatory factors to the nucleus, the nuclear architecture
can affect the genome subnuclear organisation and chro-
matin structure. In general, there is a strong correlation
between the nuclear periphery and heterochromatin
establishment and/or maintenance and accordingly gene
silencing, while the NPCs have been implicated in pre-
serving euchromatin from such a process[269,270]. More
specifically, components of the inner nuclear envelop,
lamina and NPC have been described to have an impor-
tant role in regulating gene expression. LBR, part of our
dataset, has been shown to interact with HP1 and conse-
quently regulates heterochromatin formation[271]. Other
lamin-associated proteins, such as emerin and Lap2, were
also identified as Tat interactors in our studies, have beenRetrovirology 2009, 6:47 http://www.retrovirology.com/content/6/1/47
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shown to associate with and sequester a number of tran-
scriptional repressors, including HDACs, BAF, NCoR and
beta-catenin[270,272]. The identification of numerous
crucial elements involved the nuclear architecture, as Tat
interactors, suggest that they could be involved in regulat-
ing the transcriptional state of the provirus.
Conclusion
The results presented here, position the viral regulatory
protein at the nexus of a range of interaction networks,
which play essential and diverse roles in gene expression,
RNA processing, chromatin organisation, chromosome
structure and nuclear architecture, and provide the first
insights into the modular network properties of the Tat
interactome. Ultimately, the HIV-1 Tat rewiring of cellular
networks could equip the provirus with a wide repertoire
of tools to orchestrate HIV-1 gene expression and confer a
remarkable adaptability to a continuously changing cellu-
lar environment. Overall, this confirms that Tat transacti-
vation function appears to be the net result of complex
interactions with distinct cellular complexes highly spe-
cialised in controlling gene expression and more specifi-
cally chromosome/chromatin structure. We anticipate
that the data presented here will be useful for researchers
investigating HIV-1 gene regulation and further studies
will delineate the biological significance of these findings.
Methods
Cell culture
Jurkat cell line (Clone E6-1) was maintained in RPMI
1640 medium containing 10% fetal calf serum and sup-
plemented with 0.3 mg/L of L-Glutamine (GIBCO) and
antibiotics. Nuclear extracts were prepared from Jurkat
cells with the ProteoExtract® Subcellular Proteome Extrac-
tion Kit (Calbiochem) according to the manufacturers
instructions, which include the treatment of the nuclear
fraction with Benzonase® nuclease.
Production of recombinant proteins
GST and GST-Tat (HIV-1 HXB2, 86 amino acids) recom-
binant proteins were produced in BL21 E. coli. and puri-
fied with gluthathione-Sepharose beads (Amersham) as
described previously[273].
In vitro GST-pull down assays
To create high-density ligand surface, equivalent amounts
of purified recombinant GST-Tat (bait) and GST (negative
control) proteins were added in excess and immobilised
on gluthathione-Sepharose 4 Fast flow (Amersham). The
supernatant was discarded and following extensive
washes in Binding Buffer (BB) (20 mM Tris, pH 7.4, 300
mM NaCl, 100 mM NaF, 1 mM DTT, 50 mM EDTA, 1%
triton X100, 10% glycerol and protease inhibitor cocktail
Complete, EDTA-free (Roche)), the beads were incubated
with Jurkat cell nuclear extracts (300 μg), rotating at 4°C
overnight. Following extensive washes in binding buffer,
specifically retained protein complexes were eluted from
the resin by incubating the beads in 2× Leamni sample
buffer at 95°C for 5 min.
Gel electrophoresis and Coomassie staining
The eluate was resolved on a 10% SDS-PAGE and the
resulting interaction profiles were sliced into 2 mm bands
across the entire separation range without bias with
respect to size and relatively abundance. A total of 164 gel
slices were produced.
Sample preparation for Mass Spectrometric analysis
1D gel bands were excised from the control and experi-
mental lanes and subjected to in-gel trypsin digestion.
Briefly gel bands were washed with sequential additions
of ammonium biocarbonate and acetonitrile (ACN) buff-
ers and cysteine residues were reduced and alkylated using
DTT and IAA. Samples were digested overnight with 4 ng/
μl trypsin at 37°C. Peptides were extracted using 60%
ACN, 0.2% TFA buffer and were dried and stored for sub-
sequent MS analysis.
Protein identification by LC MSMS
LC MS/MS was carried out on a Finnigan LTQ mass spec-
trometer connected to a Surveyor chromatography system
incorporating an autosampler. Tryptic peptides were
resuspended in 0.1% formic acid and were separated by
means of a modular CapaLC system (Finnigan) connected
directly to the source of the LTQ. Each sample was loaded
onto a Biobasic C18 Picofrit™ column (100 mm length,
75 μm ID) at a flow rate of 30 nL min-1. The samples were
then eluted from the C18 Picofrit™ column by an increas-
ing acetonitrile gradient. The mass spectrometer was oper-
ated in positive ion mode with a capillary temperature of
200°C, a capillary voltage of 46 V, a tube lens voltage of
140 V and with a potential of 1.8 kV applied to the frit. All
data was acquired with the mass spectrometer operating
in automatic data dependent switching mode. A zoom
scan was performed on the 5 most intense ions to deter-
mine charge state prior to MS/MS analysis.
Data analysis
All MS/MS spectra were sequence database searched using
TurboSEQUEST. The MS/MS spectra were searched
against the redundant TREMBL database. The following
search parameters were used, precursor-ion mass toler-
ance of 1.5, fragment ion tolerance of 1.0 with methio-
nine oxidation and cysteine carboxyamidomethylation
specified as differential modifications and a maximum of
2 missed cleavage sites allowed.
Western-Blotting analysis
To confirm the MS/MS identification of selected Tat-inter-
acting proteins, we performed Western-Blotting analysis,Retrovirology 2009, 6:47 http://www.retrovirology.com/content/6/1/47
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using BioTrace ™ PVDF (Pall Corporation), on one fifth of
the eluate resulting from GST-pull down as described
above, but carried out with Jurkat cell nuclear extract (150
μg) and washes in BB including various salt (NaCl) con-
centrations (300 mM, 500 mM, 800 mM and 1 M). Simi-
larly, GST-pull downs were performed with a Tat-deletion
mutant GST-Tat-NLS described elsewhere[273]. The fol-
lowing primary antibodies and their corresponding dilu-
tions were employed: CyclinT1 (H-245) at 1/1000
dilution, mSIN3a (K-20) at 1/5000 dilution, SAP18 (H-
130) at 1/5000 dilution, SPT16 (H-300) at 1/1000 dilu-
tion (Santa Cruz Biotechnology); and BAF53A at 1/2000
dilution, Ikaros at 1/4000 dilution, HDAC1 at 1/5000
dilution, SNF2H at 1/1000 dilution, WDR51/500 dilu-
tion and RbAp46/48 1/1000 dilution (Abcam). the fol-
lowing secondary antibodies (GE Healthcare) and their
corresponding dilutions were employed: ECL ™ Anti-
mouse IgG at 1/5000 dilution and ECL ™ Anti-rabbit IgG
at 1/10000 dilution.
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